Sam Chun Earnings Estimate

Sam Chun Earnings per Share Projection vs Actual

About Sam Chun Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Sam Chun earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Sam Chun estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Sam Chun fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Co., Ltd manufactures, distributes, imports, and exports pharmaceuticals in South Korea. The company was founded in 1943 and is headquartered in Seoul, South Korea. SCD is traded on Korean Securities Dealers Automated Quotations in South Korea.

Other Information on Investing in Sam Stock

Sam Chun financial ratios help investors to determine whether Sam Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sam with respect to the benefits of owning Sam Chun security.